Piramal Enterprises secured the approval of the National Company Law Tribunal (NCLT) for the demerger of its pharmaceutical business and the simplification of its corporate structure, the company said in a regulatory filing. The record date for the demerger of the pharma business from the finance business has been set as September 1 and stock traded ex-demerger on Tuesday as the markets will remain shut on Wednesday on the account Ganesh Chaturthi.
Nifty faces stiff resistance near 25,100; sector rotation is key
Markets remain cautious below the 25100 resistance, vulnerable to corrections and volatility. Sector rotation, profit protection, and modest leverage are key amid shifting momentum across